Ocular Therapeutix™ to Participate in Upcoming Investor and Scientific Conferences

BEDFORD, Mass., April 29, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, "Ocular"), a biopharmaceutical company committed to redefining the retina experience, today announced participation in several upcoming investor and scientific conferences in the first half of May 2025. Upcoming Investor Conferences Panel Title: Retina in Office Session 5: I Shall be Released: Novel Drug Delivery Approaches for Glaucoma and Retina Session Date/Time: Friday, May 2, 2025, 12:30 – 1:30 PM MT Panelist: Na ...